Image

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Study of an Investigational Treatment for Advanced Solid Tumors with KRAS G12D Mutation

Recruiting
18-75 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced solid tumors with a specific mutation known as KRAS G12D. The purpose of this study is to explore the effects of an investigational medication on these tumors.

The study evaluates the safety and effectiveness of the investigational medication. Researchers are focused on understanding how well the medication works and its safety profile in patients with the mutation.

  • Who can participate: Adults aged 18 to 75 with advanced solid tumors and a KRAS G12D mutation can participate. Participants must have a life expectancy of at least 3 months and meet specific health criteria.
  • Study details: Participants will take the investigational treatment, either alone or in combination with other treatments. Some may receive a placebo, which is an inactive substance that looks like the investigational treatment but does not contain any medicine.
Print
Study details
    Malignant Neoplasm

NCT06385925

Tyligand Pharmaceuticals (Suzhou) Limited

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.